BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 2570431)

  • 1. Blockade of acquisition of one-way conditioned avoidance responding by haloperidol and metoclopramide but not by thioridazine or clozapine: implications for screening new antipsychotic drugs.
    Blackburn JR; Phillips AG
    Psychopharmacology (Berl); 1989; 98(4):453-9. PubMed ID: 2570431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The paw test: a behavioural paradigm for differentiating between classical and atypical neuroleptic drugs.
    Ellenbroek BA; Peeters BW; Honig WM; Cools AR
    Psychopharmacology (Berl); 1987; 93(3):343-8. PubMed ID: 2893411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of clozapine, metoclopramide, haloperidol and risperidone on acquisition and performance of operant responding in rats.
    Baker TW; Florczynski MM; Beninger RJ
    Psychopharmacology (Berl); 2015 May; 232(9):1535-43. PubMed ID: 25381749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride and metoclopramide to antagonise the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic systems.
    Costall B; Naylor RJ
    Eur J Pharmacol; 1976 Nov; 40(1):9-19. PubMed ID: 791660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of the nueroleptic properties of clozapine, sulpiride and thioridazine.
    Costall B; Naylor RJ
    Psychopharmacologia; 1975 Jul; 43(1):69-74. PubMed ID: 1172258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute administration of clozapine, thioridazine and metoclopramide increases extracellular DOPAC and decreases extracellular 5-HIAA, measured in the nucleus accumbens and striatum of the rat using in vivo voltammetry.
    Maidment NT; Marsden CA
    Neuropharmacology; 1987; 26(2-3):187-93. PubMed ID: 2438582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A drug-drug conditioning paradigm reveals multiple antipsychotic-nicotine interactions.
    Feng M; Sparkman NL; Sui N; Li M
    J Psychopharmacol; 2017 Apr; 31(4):474-486. PubMed ID: 28347260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical neuroleptics clozapine and thioridazine enhance amphetamine-induced stereotypy.
    Robertson A; MacDonald C
    Pharmacol Biochem Behav; 1984 Jul; 21(1):97-101. PubMed ID: 6540455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of clozapine on shuttle-box avoidance responding in rats: comparisons with haloperidol and chlordiazepoxide.
    Sanger DJ
    Pharmacol Biochem Behav; 1985 Aug; 23(2):231-6. PubMed ID: 4059310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonism of the hyperactivity induced by dopamine applied intracerebrally to the nucleus accumbens septi by typical neuroleptics and by clozapine, sulpiride and thioridazine.
    Costall B; Naylor RJ
    Eur J Pharmacol; 1976 Jan; 35(1):161-8. PubMed ID: 1253817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct neural mechanisms underlying acute and repeated administration of antipsychotic drugs in rat avoidance conditioning.
    Li M; Sun T; Zhang C; Hu G
    Psychopharmacology (Berl); 2010 Sep; 212(1):45-57. PubMed ID: 20623111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of thioridazine, clozapine and metoclopramide on the induction of adrenomedullary enzymes by apomorphine.
    Ekker M; Sourkes TL
    Neuropharmacology; 1985 Nov; 24(11):1063-6. PubMed ID: 2867484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioural interactions between 5-hydroxytryptophan, neuroleptic agents and 5-HT receptor antagonists in modifying rodent responding to aversive situations.
    Costall B; Naylor RJ
    Br J Pharmacol; 1995 Dec; 116(7):2989-99. PubMed ID: 8680734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose clozapine pretreatment partially prevents haloperidol-induced deficits in conditioned active avoidance.
    Murphy CA; Feldon J
    Behav Pharmacol; 2000 Jun; 11(3-4):307-16. PubMed ID: 11103885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a stable CCK agonist (A68552) in conditioned avoidance responding in mice, rats, and primates: comparison with typical and atypical antipsychotics.
    Britton DR; Curzon P; Yahiro L; Buckley M; Tufano M; Nadzan A
    Pharmacol Biochem Behav; 1992 Oct; 43(2):369-76. PubMed ID: 1359571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of clozapine, thioridazine, and mezilamine with oxotremorine on schedule-controlled responding.
    Leander JD
    Psychopharmacology (Berl); 1983; 80(1):29-30. PubMed ID: 6135236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional selectivity of neuroleptic drugs: an argument for site specificity.
    Borison RL; Diamond BI
    Brain Res Bull; 1983 Aug; 11(2):215-8. PubMed ID: 6138135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential locus and mechanism of blockade of conditioned avoidance responding by neuroleptics.
    Petty F; Mott J; Sherman AD
    Neuropharmacology; 1984 Jan; 23(1):73-8. PubMed ID: 6144066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison between a new antipsychotic screening technique (shelf jump avoidance) and a classical discriminative avoidance paradigm.
    Herman RL; Malick JB; Kubena RK
    Commun Psychopharmacol; 1979; 3(3):165-71. PubMed ID: 40728
    [No Abstract]   [Full Text] [Related]  

  • 20. Subchronic administration of clozapine, but not haloperidol or metoclopramide, decreases dopamine D2 receptor messenger RNA levels in the nucleus accumbens and caudate-putamen in rats.
    See RE; Lynch AM; Sorg BA
    Neuroscience; 1996 May; 72(1):99-104. PubMed ID: 8730709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.